Elekta (STO:EKTAB) will publish its Interim Report 2014/15 on August 28,
· The report will be published at 13:00 CET.
· Elekta will host a telephone conference at 13:45-14:30 CET with Niklas
Savander, President and CEO and Håkan Bergström, CFO.
To take part in the conference call, please dial in about five minutes
in advance, use the telephone numbers below.
· UK dial-in number: +44 20 319 405 47
· US dial-in number: +1 877 788 90 23
· Swedish dial-in number: +46 8 519 993 50
The telephone conference will be broadcasted live online (for the
possibility to ask questions, please also dial in). Please use the link: http://event.onlineseminarsolutions.com/r.htm?e=835942&s=1&k=EAA8B50F1C78794463BD4A565734355A
# # #
Elekta is a human care company pioneering significant innovations and
clinical solutions for treating cancer and brain disorders. The company
develops sophisticated, state-of-the-art tools and treatment planning
systems for radiation therapy, radiosurgery and brachytherapy, as well
as workflow enhancing software systems across the spectrum of cancer
care. Stretching the boundaries of science and technology, providing
intelligent and resource-efficient solutions that offer confidence to
both health care providers and patients, Elekta aims to improve, prolong
and even save patient lives.
Today, Elekta solutions in oncology and neurosurgery are used in over
6,000 hospitals worldwide. Elekta employs around 3,800 employees
globally. The corporate headquarters is located in Stockholm, Sweden,
and the company is listed on the Nordic Exchange under the ticker
STO:EKTAB. Website: www.elekta.com.
This information was brought to you by Cision http://news.cision.com
[ Back To NFVZone's Homepage ]